OpenAI researcher Miles Wang is reportedly leaving to launch an AI drug discovery startup in talks for a $2 billion valuation
OpenAI researcher Miles Wang is reportedly launching an AI drug discovery startup, highlighting surging investor demand for life sciences AI.
